4//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4
Accession 0001209191-15-053992
CIK 0001373707operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 7:19 PM ET
Size
9.4 KB
Accession
0001209191-15-053992
Insider Transaction Report
Form 4
THOMPSON JOHN CRAIG
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2015-06-15$14.45/sh+10,000$144,500→ 10,343 total - Sale
Common Stock
2015-06-15$41.51/sh−10,000$415,100→ 343 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-06-15−10,000→ 187,501 totalExercise: $14.45Exp: 2024-02-02→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2015.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $40.77 to $42.23 per share. The reporting person herby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]This option vested as to 20% of the shares on February 3, 2014 and another 20% on February 3, 2015 and further vests as to 5% of the shares at the end of each successive three-month period thereafter until February 3, 2018.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 7:19 PM ET
- Size
- 9.4 KB